Biomarkers for Alzheimer's Disease: The Road Towards Clinical Implementation, Upcoming Webinar Hosted by Xtalks

Toronto, ON (PRWEB) May 16, 2022 -- Cerebrospinal fluid (CSF) biomarkers for Alzheimer’s disease (AD) have become the cornerstone of the etiological diagnosis

Related Keywords

United Kingdom ,Amsterdam ,Noord Holland ,Netherlands ,Pieter Van Bokhoven ,Charlotte Teunissen ,Honeycomb Worldwide Inc ,Neurochemistry Lab ,Chief Scientific Officer ,Industry Alliance Office ,Amsterdam Neuroscience ,Road Towards Clinical ,Life Science ,Press Release ,